Accolade Executive Compensation (FY24)
ACCD · Executive and director compensation, fiscal 2022 to 2024
The paid brief on Accolade
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Data as of September 8, 2026Latest filing (8-K): August 7, 2024
6 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
223 figures on this page: 220 cited to the filing that reported them, 3 calculated from figures it prints. See the citations
More on Accolade
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2023 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Rajeev Singh: $1,998,407 → $3,823,597 (91.3% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Accolade's chief executive and what were they paid?
Rajeev Singh was paid $3,823,597 in total compensation as Chief Executive Officer and Chairman of the Board for fiscal 2024. Singh's total moved 91.3% higher from the $1,998,407 reported for fiscal 2023.
What was Accolade's say-on-pay result?
For fiscal 2024, shareholders backed the say-on-pay proposal with 99.0% of votes cast for or against in favor at the meeting held August 6, 2024.
Which companies are in Accolade's peer group?
Companies named in the disclosed peer group include Agiliti, American Well, AppFolio, Computer Programs and Systems and GoodRx Holdings, among others.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Rajeev Singh Chief Executive Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | — | — not reconciled |
Robert Cavanaugh President | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | — not reconciled |
Stephen Barnes Chief Financial Officer | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | — not reconciled |
Michael Hilton Chief Innovation Officer | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | — not reconciled |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Rajeev Singh Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Stephen Barnes Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Robert Cavanaugh President | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Michael Hilton Former Chief Innovation Officer Departed during or after this year | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Rajeev Singh Chief Executive Officer and Chairman of the Board | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Robert Cavanaugh President | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Stephen Barnes Chief Financial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Richard Eskew Executive Vice President, General Counsel, and Chief Compliance Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Rajeev Singh | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Rajeev Singh | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Richard Eskew | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Richard Eskew | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Robert Cavanaugh | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Robert Cavanaugh | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Stephen H. Barnes | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Stephen H. Barnes | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2023 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Robert Cavanaugh | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | 10/30/2025 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 4/26/2027 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 5/2/2028 | |
| Option | ◇ | — | ◇ | 6/16/2030 | |
| Option | ◇ | — | ◇ | 6/15/2031 | |
| Option | ◇ | — | ◇ | 6/24/2029 | |
| Option | ◇ | — | ◇ | 6/29/2032 | |
| Stephen Barnes | Option | ◇ | — | ◇ | 4/26/2027 |
| Option | ◇ | — | ◇ | 5/2/2028 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 6/24/2029 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/1/2025 | |
| Option | ◇ | — | ◇ | 6/16/2030 | |
| Option | ◇ | — | ◇ | 6/29/2032 | |
| Option | ◇ | — | ◇ | 6/15/2031 | |
| Richard Eskew | Option | ◇ | — | ◇ | 12/20/2028 |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 4/26/2027 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 5/2/2028 | |
| Option | ◇ | — | ◇ | 6/24/2029 | |
| Option | ◇ | — | ◇ | 6/15/2031 | |
| Option | ◇ | — | ◇ | 6/16/2030 | |
| Option | ◇ | — | ◇ | 6/10/2032 | |
| Rajeev Singh | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | 10/30/2025 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 7/26/2027 | |
| Option | ◇ | — | ◇ | 6/15/2031 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 5/2/2028 | |
| Option | ◇ | — | ◇ | 6/24/2029 | |
| Option | ◇ | — | ◇ | 6/29/2032 | |
| Option | ◇ | — | ◇ | 6/16/2030 |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Rajeev Singh
Chief Executive Officer and Chairman of the Board · Terms as described in the company’s compensation discussion · citing a 2024 filing
| Severance cash amount | ◇ |
Richard Eskew
Executive Vice President, General Counsel, and Chief Compliance Officer · Terms as described in the company’s compensation discussion · citing a 2024 filing
| Equity acceleration on change in control | ◇ |
Stephen Barnes
Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2024 filing
| Severance cash amount | ◇ |
| Equity acceleration on change in control | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2024
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Peter Klein Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
Dawn Lepore | ◇ | ◇ | — | — | — | — | ◇ |
Elizabeth Nabel | ◇ | ◇ | — | — | — | — | ◇ |
Jeffrey Brodsky | ◇ | ◇ | — | — | — | — | ◇ |
Patricia Wadors | ◇ | ◇ | — | — | — | — | ◇ |
Cindy Kent | ◇ | ◇ | — | — | — | — | ◇ |
Jeffrey Jordan | ◇ | ◇ | — | — | — | — | ◇ |
Rajeev Singh and Michael Hilton served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x annual cash retainer ($434,000)
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
- Agiliti AGTI
- American Well AMWL
- AppFolio APPF
- Computer Programs and Systems symbol not shown
- GoodRx Holdings GDRX
- Health Catalyst HCAT
- HealthEquity HQY
- HealthStream HSTM
- Hims & Hers Health HIMS
- Model N MODN
- NextGen Healthcare NXGN
- NRC Health NRC
- Phreesia PHR
- Progyny PGNY
- Sharecare SHCR
- Tabula Rasa HealthCare TRHC
- Yext YEXT
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2024 | August 6, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | August 8, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | July 26, 2022 | = | ◇ | ◇ | ◇ |
What this page does not include
Everything above is a fact Accolade disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Accolade sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
223 figures on this page: 220 cited to the filing that reported them, 3 calculated from figures it prints.
220 cited to the filing
3 calculated from the filing
Documents cited
- 0001481646-24-000042
- 0001481646-24-000029Compensation Discussion and Analysis · Director Compensation · Director Compensation for the Fiscal Year Ended February 29, 2024 · OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END · and 1 more section
- 0001558370-23-014251
- 0001558370-23-011456SUMMARY COMPENSATION TABLE
- 0001104659-22-083321
- 0001104659-22-074317
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Accolade executive compensation, FY2022–FY2024.” https://intel.velarion.ai/comp/ACCD (accessed 2026).
Short form: data: Velarion
The paid brief for Accolade
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
6 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Accolade and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Accolade discloses
The companies named in ACCD's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}